USFDA auditors have inspected Shilpa Medicare Ltd’s manufacturing facilities located at Deosugur Industrial Area, Deosugur, Raichur (Karnataka).
The auditors have also inspected its 100 per cent EOU facility at Raichur Industrial Growth Centre, Wadloor Road, Chicksugur Cross, Chicksugur, Raichur (Karnataka).
The company in a release to exchanges said that the results of the audit are awaited.
Business Line
Pearson Syndrome is an extremely rare condition and the prevalence is approximately 1 in a…
A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…
People who smoke are also at much higher risk of developing diabetes compared to non-smokers…
17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…
Lonavala, November 12, 2024: As the global cancer burden rises to 30 million cases by…
The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…